We have developed a manufacturing process to convert donated blood plasma and platelets into inexpensive, off-the-shelf bioactive plastics to enhance and accelerate tissue healing. These materials contain nature’s own mix of growth factors in highly concentrated solid to semi-solid forms that controllably elute these factors as the bioplastics degrade. This technology is currently in human clinical trials.
Blood-Plasma Based Bioplastics
Displaying 0 Publications